Navigation Links
Americans Optimistic About the War on Cancer

Despite it being the number two killer in our nation, Americans are very optimistic about the war against cancer. In fact, according to a recent nationwide survey sponsored by Abbott, nearly two-thirds (64%) believe the scientific community is winning the war against cancer.

"As an organization researching new options to fight cancer, Abbott is hopeful that its efforts will live up to the optimism expressed by Americans regarding the future of cancer therapy," said John Leonard, M.D., vice president, Global Research and Development, Abbott. "With cancer accounting for nearly 25 percent of all deaths in the United States, we're focused on investigating targeted, less toxic therapies that fill unmet treatment needs."

While most Americans believe that cancer breakthroughs are on the horizon, less than half think a major breakthrough is near. Four out of five (82%) surveyed expect to see new breakthroughs in the next 25 years, but only 42 percent see those breakthroughs occurring in the next decade.

The survey results come just before the American Society of Clinical Oncology (ASCO) Annual Meeting commences in Chicago on June 1. Leading cancer researchers come together each year at the ASCO Annual Meeting to share medical advances and revolutionary approaches to cancer treatment. During the meeting, scientists from independent academic institutions and Abbott will present data on several of Abbott's investigational anti-cancer compounds including a PARP inhibitor (ABT-888) that seeks to enhance the effectiveness of common cancer therapies, a multi-targeted kinase inhibitor (ABT-869) being investigated to suppress tumor growth by cutting off its blood supply and an antimitotic agent (ABT-751) that has shown early promise in the treatment of pediatric neuroblastoma.

In addition, an Abbott scientist will lead an educational session on Abbott's Bcl-2 family protein inhibitors (ABT-263) which restore apoptosis -- the natural process by which damaged or unwanted cells die and are cleared from the body.

According to the survey, Americans also recognize that progress in the fight against cancer is already being made. Four out of five (83%) believe the chances of surviving cancer are better now than they were ten years ago. And almost half (48%) think the chances of survival are "much better" today.

"Abbott has several promising anti-cancer compounds in its oncology pipeline that may prove to be very effective in the fight against cancer," said Stephen Fesik, Ph.D., divisional vice president, Cancer Research, Abbott. "We are committed to exploring new cutting-edge therapies that may enable patients to live longer and healthier lives. Our strategy involves targeting the differences between cancer cells and normal cells and taking away the key fundamental needs of cancer."

More than 1,000 respondents participated in the telephone survey sponsored by Abbott. The goal of the survey was to assess Americans' perceptions of cancer research and their outlook regarding new treatments. Opinion Research Corporation conducted the research.


'"/>




Related medicine news :

1. Poll Finds Many Americans Misinformed About Cancer
2. Poll Finds Many Americans Misinformed About Cancer
3. Hypertension Drug of Choice for African Americans
4. 38 million Americans including 14 million children left to combat hunger
5. Americans Consume Far Too Much Salt and Sodium
6. Americans Growing Out Of Shape
7. Rise in Stress among Americans
8. Home Remedies More Used By Blacks And Native Americans
9. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
10. Aspirin, Not Used By African Americans And Diabetics To Prevent Heat Problems
11. Americans Not Interested In Choosing Sex Of Child: Survey
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... ... , ... Splashtop Inc., the worldwide leader in high performance cross-screen access, ... leading provider of secure mobile remote access solution for Japan enterprises. , ... solution. Splashtop for CACHATTO will be available as an integrated add-on secure ...
(Date:5/31/2016)... ... , ... DDL, Inc. announced today it has expanded the scope of its ... 594-1 and ISO 594-2 testing for conical (Luer) fittings. , A conical Luer ... devices (e.g. a syringe and hypodermic needle) that carry small volumes of fluids. There ...
(Date:5/31/2016)... ... 2016 , ... Like jewels in a crown, the multiple awards presented to ... to Ontario’s leading day spa and one of Canada’s few accredited 5 Star Spas! ... concept to combine spa services with hair and beauty services and has ...
(Date:5/31/2016)... ... May 31, 2016 , ... The Orthopaedic Research and Education ... , David G. Lewallen, MD, began his term as president in March, succeeding ... Parks, MD, is OREF’s new president-elect. Richard F. Kyle, MD, will serve as chair, ...
(Date:5/31/2016)... Aviv (PRWEB) , ... May 31, 2016 , ... ... the May 4, 2016 Cool Vendors in Security Infrastructure Protection report by Gartner1 ... and publishes a series of research reports evaluating these innovative vendors and their ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... LONDON , May 30, 2016 ... to eliminate viral hepatitis by 2030. At the 69 th ... first ever Global Viral Hepatitis Strategy, signalling the greatest global ... sets a goal of eliminating hepatitis B and C by ... which, if reached, will reduce annual deaths by 65% and ...
(Date:5/30/2016)... DUBAI , May 30, 2016 ... parents of premature babies to seek an eye examination ... avoid blinding condition     Moorfields Eye ... Hospital in London , has identified premature babies ... vision problems, because of their particular vulnerability to retinopathy of prematurity ...
(Date:5/27/2016)... 2016 According to the 2016 ... driving ambulatory blood pressure monitoring system market growth. With ... ability to respond to different pressure rates, leading to ... to various cardiovascular disorders such as heart failure, stroke, ... are growing in prevalence each year. WHO estimates that ...
Breaking Medicine Technology: